Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)

NCT05384821 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Wilms Tumor

Interventions

DRUG: Vincristine
DRUG: Irinotecan
DRUG: Temozolomide
DRUG: Etoposide
DRUG: Cis-Retinoic acid

Sponsor

Centre Oscar Lambret